Navigation Links
Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show

itions or strategies and other financial and business matters, including expectations regarding future revenues, product safety or efficacy, patent protection, operating expenses, and clinical developments are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by Novavax to secure and maintain relationships with collaborators; risks relating to the early stage of Novavax's product candidates under development; uncertainties relating to clinical trials; risks relating to the commercialization, if any, of Novavax's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.

CONTACT: Mariann Caprino of Novavax Inc., +1-240-268-2029

Web site: http://www.novavax.com/http://tinyurl.com/2q9wla/

Ticker Symbol: (NASDAQ-NMS:NVAX)

Terms and co
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
2. Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
5. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
6. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
7. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
8. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
9. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
10. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
11. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... April 29, 2011 Centocor Ortho Biotech Products, L.P., ... Drug Application (NDA) for trabectedin for the treatment of ... based on the U.S. Food and Drug Administration,s (FDA) ... to obtain approval. The NDA was submitted ...
... Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy ... of the Year. The award was announced at ... annual award along with Grant Thornton LLP, WWJ Newsradio 950 ... Hagerman was chosen from among 45 nominees profiled during the ...
Cached Medicine Technology:Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 3
(Date:7/7/2015)... Chicago, IL (PRWEB) , ... July 07, 2015 ... ... organized the only industry group whose board is limited to permit holders. The ... vision on how to move the industry forward and are committed to making ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great time to ... Amica Insurance is sharing some safety tips. , Jean Tapley, senior wellness coordinator at ... activities/sports, , Start slowly. Going from no activity to several ...
(Date:7/7/2015)... ... July 07, 2015 , ... On June 22nd-26th, 2015, the ... the National Baptist Convention 110th Annual Session of the National Baptist Congress of ... of churches and their congregations, medical professionals and health-related organizations, this week long ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... and creative design firm, today announced that TimberNook ( http://www.timbernook.com/ ) ... media campaign, content strategy, and marketing launch package for new camp providers. ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... educated and motivated leaders with strong managerial expertise to oversee large healthcare ... with patients, staff, providers, business partners, insurance companies, and regulators. American Sentinel ...
Breaking Medicine News(10 mins):Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4
... to generate artificial muscles, a Harvard University professor is ... help robots move like living creatures. Dr. Ali ... has earned him a spot among 94 scientists and ... government award for young professionals on the cusp of ...
... a doctor when you get old! 9. Please show the same ... 8. Grandma will thank you. (Washington) The American College of ... should repeal the SGR (sustainable growth rate) now. The rest ... the #1 reason to be made known on Wed., Nov. 16. ...
... Since 1928, the way breast cancer characteristics are evaluated ... by hand, under a microscope. Pathologists examine the tumors ... developed eight decades ago. These scores help doctors assess ... to calculate the patient,s prognosis and course of treatment. ...
... (HealthDay News) -- A new study suggests that the ... a precancerous lesion that is often a forerunner to ... against human papillomavirus (HPV) types 16 and 18, which ... particularly effective when given to adolescent girls before they ...
... players experience repeated head trauma throughout their careers, ... their cognitive function, physical and mental health. University ... factors, including diet and exercise, impact the late-life ... researchers found that former football players experience more ...
... Washington, DC -- Thirty-three research institutions, associations, and foundations ... commitment to Open Access to research by signing the ... Sciences and Humanities. These top private, public, and non-profit ... in another clear sign of the growing demand for ...
Cached Medicine News:Health News:Office of Naval Research young investigators honored with Presidential Award 2Health News:Office of Naval Research young investigators honored with Presidential Award 3Health News:Office of Naval Research young investigators honored with Presidential Award 4Health News:Stanford team trains computer to evaluate breast cancer 2Health News:Stanford team trains computer to evaluate breast cancer 3Health News:More Evidence That HPV Vaccine Shields Against Cervical Cancer 2Health News:Former football players prone to late-life health problems, MU study finds 2Health News:Leading North American institutions endorse the Berlin Declaration on Open Access to Knowledge 2Health News:Leading North American institutions endorse the Berlin Declaration on Open Access to Knowledge 3